Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transfusion ; 44(6): 891-9, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15157257

RESUMO

BACKGROUND: Previous reports have shown that storage decrease the ability of PLTs to aggregate in the form of PLT concentrate (PC). Nevertheless, there are few reports that have studied the PLT function in blood samples obtained from recipients after PLT transfusion. In this study, this issue was addressed by examining the ability of PLTs to aggregate after being transfused into the blood stream. STUDY DESIGN AND METHODS: PC was transfused to the patients with extremely low PLT counts resulting from chemotherapy. The maximum extent of PLT aggregation and size of the aggregates were compared between PLT in stored PC before transfusion with the PLT-rich plasma (PRP) from the recipients after transfusion and with PRP from patients with moderate decrease in PLT counts after chemotherapy. RESULTS: The maximum extent of PLT aggregation was significantly higher in PRP collected from the patients after transfusion compared to the extent obtained before transfusion. There were no significant differences in the maximum extents of PLT aggregation between the PRP collected from the recipients after PC transfusion and, in the same patients, when PLT counts were moderately low. CONCLUSION: These results suggest that the observed decreased in PLT aggregation after storage can improve in the body after transfusion, and transfused PLTs have similar aggregation ability compared to the PLTs derived from the patient.


Assuntos
Preservação de Sangue , Agregação Plaquetária , Transfusão de Plaquetas , Difosfato de Adenosina/farmacologia , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Criança , Pré-Escolar , Colágeno/farmacologia , Feminino , Humanos , Leucemia/sangue , Leucemia/complicações , Leucemia/tratamento farmacológico , Masculino , Melanoma/sangue , Melanoma/complicações , Melanoma/tratamento farmacológico , Agregação Plaquetária/efeitos dos fármacos , Contagem de Plaquetas , Recuperação de Função Fisiológica , Trombocitopenia/sangue , Trombocitopenia/induzido quimicamente , Trombocitopenia/terapia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...